SUBSTITUTED BICYCLIC DIHYDROPYRIMIDINONES AND THEIR USE AS INHIBITORS OF NEUTROPHIL ELASTASE ACTIVITY
申请人:Boehringer Ingelheim International GmbH
公开号:US20160031829A1
公开(公告)日:2016-02-04
Substituted bicyclic dihydropyrimidinones of formula 1
which are inhibitors of neutrophil elastase and useful as medicaments for the treatment of, inter alia, COPD. An exemplary compound is:
公式1中的取代双环二氢
嘧啶酮是中性粒细胞弹性蛋白酶抑制剂,可用作治疗
COPD等疾病的药物。其中一种典型的化合物是: